Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients

OBJECTIVES: Cytomegalovirus (CMV) infections in liver transplant recipients are common and result in significant morbidity and mortality. Intravenous ganciclovir or oral valganciclovir are the standard treatment for CMV infection. The present study investigates the efficacy of oral valganciclovir in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jong Man, Kwon, Choon Hyuck David, Joh, Jae-Won, Ha, Young Eun, Sinn, Dong Hyun, Choi, Gyu-Seong, Peck, Kyong Ran, Lee, Suk-Koo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420490/
https://www.ncbi.nlm.nih.gov/pubmed/25942443
http://dx.doi.org/10.1371/journal.pone.0123554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420490/
https://www.ncbi.nlm.nih.gov/pubmed/25942443
http://dx.doi.org/10.1371/journal.pone.0123554

Ejemplares similares